Advertisement

Topics

Search Results for "Biosoft Pharma"

20:30 EDT 30th March 2017 | BioPortfolio

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Zyme Communications

Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value, and generate interest from commercial leads...

Matching News

PREMIER Biosoft Announces SimLipid® 5.50 for Shotgun Lipidomics Data Analysis

Palo Alto, California (PRWEB) December 19, 2016 PREMIER Biosoft today announced the release of SimLipid® v. 5.50, which provide...

PREMIER Biosoft International Announces The Release Of Simlipid 5.50 To Support Automated Data Analysis For Shotgun Lipidomics

  Life Sciences Jobs   ...

PREMIER Biosoft Announces the Release of SimLipid® 5.50 to Support Automated Data Analysis for Shotgun Lipidomics

Palo Alto, CA, December 22, 2016 --(PR.com)-- PREMIER Biosoft today announced the release of SimLipid® v. 5.50, which provides an automated data analysis solution for shotgun lipidomics workflow...

VERONA PHARMA PLC - Issue of Equity

PR NewswireLondon, December 29 Verona Pharma plc ("Verona Pharma" or the "Company") Exercise of Options Verona Pharma plc (AIM: VRP), the drug development company focused on first-in-class medicin...

NASDAQ OMX Nordic: Derivatives: Anticipated adjustment in Karo Pharma due to rights issue (02/17)

The following information is based on a press release from Karo Pharma AB (Karo Pharma) published on January 16, 2017 and may be subject to change. The board of Karo Pharma has proposed that the Ex...

Tetra Bio-Pharma Inc. Announces a New Appointment to its Scientific and Clinical Advisory Board

OTTAWA, ONTARIO -- (Marketwired) -- 01/11/17 -- PhytoPain Pharma Inc. ("PhytoPain Pharma" or "PPP"), a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE: TBP)(CSE: TBP.CN)(OTC PI...

Mezzion hires Pol Pharma and Halo Pharma and accuses Dr Reddy's of fraud

Mezzion has hired Pol Pharma and Halo Pharma and accused former CMO Dr Reddy’s of hiding manufacturing problems that cost its erectile dysfunction candidate, udenafil, US approval.

Top 32 Pharma companies: Perception of Pharma Companies Pairing of the Most Admired Pharma Companies – A Survey by eyeforpharma, its mission is to make Pharma companies more open and valued

Top 32 Pharma companies: Perception of Pharma Companies Pairing of the Most Admired Pharma Companies – A Survey by eyeforpharma, its mission is to make Pharma companies more open and valued R...

Matching PubMed Articles

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Scratching the Career Itch Leads To Bigger Reach in Pharma.

A Review of "Big Pharma, Women, and the Labour of Love"by Thea Cacchioni. Toronto, Canada: University of Toronto Press, 2015, 167 pages, $50.00 (hardcover), $21.95 (paperback), $20.85 (Kindle).

AMCP Seeks an End to 20 Years Of Confusion Over FDAMA Section 114.

The FDA never issued regulations to clarify the boundaries of promotion of pharmacoeconomic data, something it's been dragging its feet on for nearly 20 years. In turn, pharma companies, fearful of be...

▼Pitolisant for narcolepsy.

▼Pitolisant (Wakix-Bioprojet Pharma) is a new treatment for adults with narcolepsy with or without cataplexy. It was licensed for use in the EU in March last year and has orphan drug status.(1) Here...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement